Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
9
self-reported 2–10 band
Founded
2015
11 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
SANGUI BIO PTY LTD
ABN88607151477
Legal entities
Show as table · Sangui Bio: 1 registry entity
| SANGUI BIO PTY LTD | ABN 88607151477 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Founded in 2015, Sangui Bio is a Sydney-based life sciences company aiming to revolutionise how blood is analysed and used in medicine by shifting the focus to red blood cells (RBCs). We are creating powerful diagnostics and therapeutics for a range of inflammatory conditions with an initial focus on cancer, pregnancy related complications, diabetes, and renal failure. Since its foundation, Sangui Bio has worked in collaboration with the University of Sydney, the Kolling Institute, and the Future Project at the King’s School.
One of the first steps in biomarker discovery is the analysis of clinical blood samples, and more specifically the serum or plasma component of blood. Isolating serum or plasma simplifies the processing and analysis of blood by removing the other cellular components. Whilst this is valuable, it provides an incomplete picture of inflammation. The plasma is only one part of a much more complex signalling network, and red blood cells have now been identified as a major signalling protein reservoir. Signalling molecules such as cytokines are frequently analysed in biomarker discovery projects and their activities are increasingly targeted by therapeutics.
In 2014, the founding scientists of Sangui Bio made the discovery that RBCs are a major reservoir of signalling proteins, such as cytokines. We found that intact RBCs bind and release these proteins in a controlled manner over time, and that the protein profile of these cells could be manipulated by adjusting the storage conditions of these cells. Our data on blood samples from healthy people and multiple diseases indicate that RBCs act as a ‘buffer’ that may be involved in homeostasis.
We have developed technology and protocols for gentle isolation of RBCs from whole blood and in the isolation of cell secretions from RBCs and RBC components. Our intellectual property (IP) covers a broad range of techniques and clinical indications, creating value for partnering with larger companies.
Specialties
All 7 specialties
- Proteomics
- Multi-plex immunoassys
- Blood fractionation
- Cytokine binding and release
- Modulation of RBC function
- RBC membranes
- Disease profiling using RBCs
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUKolling Institute, Building 6, Reserve Rd, St Leonards; Sydney, NSW 2065Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Sangui Bio?
One New South Wales entity on the ABR: SANGUI BIO PTY LTD (ABN 88 607 151 477), high confidence.
How many people work at Sangui Bio?
9 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Sangui Bio have offices?
One address on record, Australia only. Primary: Kolling Institute, Building 6, Reserve Rd, St Leonards, Sydney, NSW 2065.
Has Sangui Bio raised funding?
None linked to this brand.
What does Sangui Bio list as its specialties?
Seven tags on the brand's own list, among them Proteomics, Multi-plex immunoassys and Blood fractionation.
Which companies are listed alongside Sangui Bio?
3 profiles list Sangui Bio as a peer — 49th percentile in Biotechnology Research. It lists ten peers of its own. Be In Motion and Drop Bio Health list it back.